Catalent, Inc. 4/A SEC Filings

Filed On	Filing
12 Dec 2023	Form 4/A: Hunt Patricia, Pres. Consumer Health Div Disposed of 289 shares (Other Transaction) · Acquired 106 shares (Other Transaction)
12 Dec 2023	Form 4/A: Pravda Ricardo, Chief Transformation Officer Disposed of 1,081 shares (Other Transaction) · Acquired 379 shares (Other Transaction)
12 Dec 2023	Form 4/A: Lickfold Charles, SVP, CIO Disposed of 637 shares (Other Transaction) · Acquired 190 shares (Other Transaction)
12 Dec 2023	Form 4/A: Fasman Steven L, EVP & Chief Admin Officer Disposed of 2,226 shares (Other Transaction) · Acquired 817 shares (Other Transaction)
12 Dec 2023	Form 4/A: Carletti Lorenzo, SVP Global Ops Ph & Cons Hlth Disposed of 457 shares (Other Transaction) · Acquired 216 shares (Other Transaction)
12 Dec 2023	Form 4/A: Gennadios Aristippos, Group Pres. Pharma & Consumer Disposed of 1,590 shares (Other Transaction) · Acquired 396 shares (Other Transaction)
12 Dec 2023	Form 4/A: Hawkeswood Thomas W, Pres. Pharma Prod Delivery Div Disposed of 268 shares (Other Transaction) · Acquired 147 shares (Other Transaction)
12 Dec 2023	Form 4/A: Hopson Ricky, Pres. Clinical Dev Supply Div Disposed of 789 shares (Other Transaction) · Acquired 276 shares (Other Transaction)
12 Dec 2023	Form 4/A: Maselli Alessandro, Director Disposed of 3,974 shares (Other Transaction) · Acquired 2,071 shares (Other Transaction)
12 Dec 2023	Form 4/A: Grippo Michael J, SVP, Strategy & Corp. Dev. Disposed of 1,114 shares (Other Transaction) · Acquired 390 shares (Other Transaction)
12 Dec 2023	Form 4/A: Gunther Scott, SVP, Quality & Reg. Affairs Disposed of 1,081 shares (Other Transaction) · Acquired 269 shares (Other Transaction)
12 Dec 2023	Form 4/A: Arnold Jonathan, SVP, CCO & Div. Head BioP Del. Disposed of 1,590 shares (Other Transaction) · Acquired 87 shares (Other Transaction)
23 Oct 2019	Form 4/A: Buzy Peter L, President, Gene Therapy Granted 231,700 Options to purchase Common Stock
04 Sep 2018	Form 4/A: Miyamoto Lance, SVP, Human Resources Gave up 987 shares to cover exercise price or tax ($43.1K)
04 Sep 2018	Form 4/A: Maselli Alessandro, SVP, Global Operations Gave up 427 shares to cover exercise price or tax ($18.6K)
04 Sep 2018	Form 4/A: Littlejohns Barry, President, Biologics & SDD Gave up 944 shares to cover exercise price or tax ($41.2K)
04 Sep 2018	Form 4/A: Joseph Wetteny, SVP & Chief Financial Officer Gave up 502 shares to cover exercise price or tax ($21.9K)
04 Sep 2018	Form 4/A: Hegwood Paul W Jr, President, CSS Gave up 505 shares to cover exercise price or tax ($22K)
04 Sep 2018	Form 4/A: Gunther Scott, SVP, Quality & Reg. Affairs Gave up 590 shares to cover exercise price or tax ($25.8K)
04 Sep 2018	Form 4/A: Fasman Steven L, SVP & General Counsel Gave up 1,063 shares to cover exercise price or tax ($46.4K)

Comments